Breast Cancer Res Treat. 2013 Jun;139(3):621-37. doi: 10.1007/s10549-013-2559-1. Epub 2013 May 31.
Rouzier R., Pronzato P., Chéreau E., Carlson J., Hunt B., Valentine W.J.
Systematic Review: The review identified 29 publications that reported evaluations of two assays: Oncotype DX(®) and MammaPrint. Studies of both tests provided evidence that their routine use was cost saving or cost-effective versus conventional approaches.
Read more: Rouzier et al_2013_Breast Cancer Res Treat._Multigene Assays and Molecular Markers…